Tissue inhibitor of metalloproteinases-1 (TIMP-1) mRNA is elevated in advanced stages of thyroid carcinoma
1999

TIMP-1 Levels in Advanced Thyroid Cancer

Sample size: 39 publication Evidence: moderate

Author Information

Author(s): Shi Y, Parhar R S, Zou M, Hammami M M, Akhtar M, Lum Z-P, Farid N R, Al-Sedairy S T, Paterson M C

Primary Institution: King Faisal Specialist Hospital and Research Centre

Hypothesis

High levels of TIMP-1 mRNA are associated with advanced stages of thyroid carcinoma.

Conclusion

The study found that high levels of TIMP-1 transcripts in advanced thyroid carcinoma likely originate from stroma rather than the cancer cells themselves.

Supporting Evidence

  • TIMP-1 mRNA levels correlated directly with tumour aggressiveness.
  • The highest number of TIMP-1 transcripts was found in stages III and IV compared to benign goitre.
  • Immunohistochemical study showed strong TIMP-1 staining in the stroma cells of advanced carcinomas.
  • Overexpression of TIMP-1 suppressed the malignant phenotype of NPA cells.

Takeaway

This study shows that a protein called TIMP-1 is found in higher amounts in advanced thyroid cancer, which might help stop the cancer from spreading.

Methodology

The expression of TIMP-1 was examined in thyroid tumor specimens and cell lines, and its effect on cell invasion was assessed through gene transfer and in vitro assays.

Statistical Information

P-Value

<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690198

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication